Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
- Oktober -
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
- 2020 -
2021
-
2022
-
2023
-
2024
Oktober 2020 - 54 products
L
IP
V/S
Influvac Tetra 0.5 ml
9.58
19.20
10 %
Mylan Pharma GmbH
B / SL
FB
G
L
IP
Mayzent 1.00 mg
28
1288.86
1476.50
10 %
Coated tablets: Siponimodum 1 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
V/S
Influvac Tetra 0.5 ml
10
PR
PR
k.A.
Mylan Pharma GmbH
B
FB
G
IP
CI
Alfuzosin-Mepha retard
10
4.89
9.70
10 %
Delayed release tablets: Alfuzosini Hydrochloridum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Alfuzosin-Mepha retard
30
13.91
28.30
10 %
Delayed release tablets: Alfuzosini Hydrochloridum 10 mg
Mepha Pharma AG
●
B / SL / SG
FB
G
IP
CI
Alfuzosin-Mepha retard
90
38.12
60.20
10 %
Delayed release tablets: Alfuzosini Hydrochloridum 10 mg
Mepha Pharma AG
●
B / SL / SG
FB
G
L
IP
CI
Agomelatin Spirig HC 25 mg
28
26.20
46.50
10 %
Coated tablets: Agomelatinum 25 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Agomelatin Spirig HC 25 mg
98
88.95
118.65
10 %
Coated tablets: Agomelatinum 25 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Agomelatin Zentiva 25 mg
28
26.20
46.50
10 %
Coated tablets: Agomelatinum 25 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Agomelatin Zentiva 25 mg
98
88.95
118.65
10 %
Coated tablets: Agomelatinum 25 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Agomelatin-Mepha 25 mg
28
26.20
46.50
10 %
Coated tablets: Agomelatinum 25 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Agomelatin-Mepha 25 mg
98
88.95
118.65
10 %
Coated tablets: Agomelatinum 25 mg
Mepha Pharma AG
●
B / SL / SG
FB
G
L
IP
CI
Ambrisentan Devatis 5 mg
30
990.57
1149.05
10 %
Coated tablets: Ambrisentanum 5 mg
Devatis AG
B / SL / SG
FB
G
L
IP
Ambrisentan Devatis 10 mg
30
990.57
1149.05
10 %
Coated tablets: Ambrisentanum 10 mg
Devatis AG
B / SL / SG
FB
G
L
IP
CI
Ambrisentan-Mepha 5 mg
30
990.57
1149.05
10 %
Coated tablets: Ambrisentanum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Ambrisentan-Mepha 10 mg
30
990.57
1149.05
10 %
Coated tablets: Ambrisentanum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Dasatinib Sandoz 20 mg
60
484.40
573.05
10 %
Coated tablets: Dasatinibum 20 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Dasatinib Sandoz 50 mg
60
1072.75
1239.25
10 %
Coated tablets: Dasatinibum 50 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Dasatinib Sandoz 70 mg
60
1072.75
1239.25
10 %
Coated tablets: Dasatinibum 70 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Dasatinib Sandoz 100 mg
30
1102.52
1271.95
10 %
Coated tablets: Dasatinibum 100 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Dutasterid Tamsulosin
Zentiva 0.5 mg/ 0.4 mg
7
3.71
8.35
10 %
Capsules: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Dutasterid Tamsulosin
Zentiva 0.5 mg/ 0.4 mg
30
15.87
34.65
10 %
Capsules: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Dutasterid Tamsulosin
Zentiva 0.5 mg/ 0.4 mg
90
47.61
71.15
10 %
Capsules: 2 Active Agents
Helvepharm AG
●
B / SL / SG
FB
G
L
IP
CI
Lenalidomid Zentiva 2.5 mg
21
689.23
808.40
10 %
Capsules: Lenalidomidum 2.5 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
Lenalidomid Zentiva 5 mg
21
707.76
829.70
10 %
Capsules: Lenalidomidum 5 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
Lenalidomid Zentiva 7.5 mg
21
726.28
851.00
10 %
Capsules: Lenalidomidum 7.5 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
Lenalidomid Zentiva 10 mg
21
744.81
872.30
10 %
Capsules: Lenalidomidum 10 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
Lenalidomid Zentiva 15 mg
21
782.79
915.95
10 %
Capsules: Lenalidomidum 15 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
Lenalidomid Zentiva 20 mg
21
821.96
960.95
10 %
Capsules: Lenalidomidum 20 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
Lenalidomid Zentiva 25 mg
21
861.14
1005.95
10 %
Capsules: Lenalidomidum 25 mg
Helvepharm AG
A / SL / SG
FB
G
IP
CI
Dienogest Sandoz 2 mg
28
43.43
66.30
10 %
Tablets: Dienogestum 2 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Dienogest Sandoz 2 mg
3 x 28
110.73
143.65
10 %
Tablets: Dienogestum 2 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Entyvio subkutan 108 mg
544.26
641.85
10 %
Injection solution in prefilled syringe: Vedolizumabum 108mg / 0.68ml
Takeda Pharma AG
A / SL
FB
G
L
IP
CI
Isturisa 1 mg
60
1441.36
1643.90
10 %
Coated tablets: Osilodrostatum 1 mg
Recordati AG
A / SL
FB
G
L
IP
Isturisa 5 mg
60
5766.51
6162.70
10 %
Coated tablets: Osilodrostatum 5 mg
Recordati AG
A / SL
FB
G
L
IP
Isturisa 10 mg
60
6067.01
6471.00
10 %
Coated tablets: Osilodrostatum 10 mg
Recordati AG
A / SL
FB
G
L
IP
CI
Mayzent 0.25 mg
12
230.16
280.90
10 %
Coated tablets: Siponimodum
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Mayzent 0.25 mg
120
1380.92
1577.55
10 %
Coated tablets: Siponimodum
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
Mayzent 2.00 mg
28
1288.86
1476.50
10 %
Coated tablets: Siponimodum 2 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Entyvio subkutan 108 mg
544.26
641.85
10 %
Injektionslösung in einem Fertigpen: Vedolizumabum 108mg / 0.68ml
Takeda Pharma AG
A / SL
FB
G
IP
CI
Ambrisentan Devatis 5 mg
10
PR
PR
k.A.
Coated tablets: Ambrisentanum 5 mg
Devatis AG
B
FB
G
IP
Ambrisentan Devatis 10 mg
10
PR
PR
k.A.
Coated tablets: Ambrisentanum 10 mg
Devatis AG
B
FB
G
IP
Dasatinib Sandoz 80 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 80 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Dasatinib Sandoz 140 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 140 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
Dienogest Sandoz 2 mg
6 x 28
PR
PR
k.A.
Tablets: Dienogestum 2 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Ozalin 2 mg/ml
PR
PR
k.A.
Solution (oral): Midazolamum 10 mg
Primex
Pharmaceuticals AG
A
FB
G
Ozalin 2 mg/ml
5
PR
PR
k.A.
Solution (oral): Midazolamum 10 mg
Primex
Pharmaceuticals AG
A
FB
G
Ozalin 2 mg/ml
10
PR
PR
k.A.
Solution (oral): Midazolamum 10 mg
Primex
Pharmaceuticals AG
A
FB
G
Paliperidon-Mepha i.m. 25 mg
PR
PR
k.A.
Retardsuspension: Paliperidonum 25 mg
Mepha Pharma AG
B
FB
G
Paliperidon-Mepha i.m. 50 mg
PR
PR
k.A.
Retardsuspension: Paliperidonum 50 mg
Mepha Pharma AG
B
FB
G
Paliperidon-Mepha i.m. 75 mg
PR
PR
k.A.
Retardsuspension: Paliperidonum 75 mg
Mepha Pharma AG
B
FB
G
Paliperidon-Mepha i.m. 100 mg
PR
PR
k.A.
Retardsuspension: Paliperidonum 100 mg
Mepha Pharma AG
B
FB
G
Paliperidon-Mepha i.m. 150 mg
PR
PR
k.A.
Retardsuspension: Paliperidonum 150 mg
Mepha Pharma AG
B
FB
G
IP
CI
Canephron
30
PR
PR
k.A.
überzogene Tabletten: 3 Active Agents
Biomed AG
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
